11 research outputs found

    TBEV cytopathic effect in porcine kidney cells.

    No full text
    <p>Confluent monolayers of PS cells were infected at an moi of 1, in at least 4 replicates and incubated for 96 hours followed by staining with crystal violet and quantification of viable cells (grey blocks) as described in Materials and methods. Error bars reflect 95% confidence intervals.</p

    Chimaeric virus growth kinetics in cell culture.

    No full text
    <p>Viruses are specified as shown in the text. PS cells were infected with TBEV at a multiplicity of 1 pfu per cell in at least 4 replicates. Samples of cell culture media were collected every 4 hours during the first day pi and then once a day. Virus infectivity was established by plaque assay. A-C) HyprIC and Hypr-based recombinant viruses; D-F) VsIC and Vs-based recombinant viruses. Error bars reflect 95% confidence intervals.</p

    Impact of genetic background on NVT of TBEV.

    No full text
    <p>A) Correlation of non-viratemic transmission (NVT) rates of different TBEV chimaeras with reproduction rate in different life stages of ticks. The trend lines are estimated by the polynomial method. The Pearson`s correlation coefficients between NVT rate (solid trend line) and titres in ticks (dashed lines) are shown by brackets with indicated r values. B) Correlation of TBEV gene replacements with NVT rate. The solid and dashed trend-lines reflect the changes in Hypr and Vs NVT rate efficiency respectively, in correspondence with size of exchanged gene fragments. Trend-lines were drawn using order 3 polynomial method with R-square value shown at the right end of the corresponding trend line. C) Correlation between NVT rate and the amino acid substitutions. The amino acid differences between C-prM-E region of polyprotein of control and chimaeric viruses are plotted on the X-axis as number of amino acid substitutions per site in comparison to VsIC sequence. The NVT rates are plotted on the Y-axis. The linear regression is calculated using equation [Y = 914.53*X + 4.77] and shown as solid line (goodness of fit R<sup>2</sup> = 0.58). The Pearson’s correlation coefficient (r) is shown in top left corner of the panel.</p

    Efficiency of non-viraemic transmission of SIB-TBEV (Vs) and EU-TBEV (Hypr) between co-feeding <i>I</i>. <i>ricinus</i>.

    No full text
    <p>Two infected female ticks were placed in close proximity to 15 uninfected nymphs on the same skin site of laboratory mice. Following three days of co-feeding, nymphs were removed and virus titres determined by plaque titration. The mean transmission rate is expressed as percentage of positive nymphs in which TBEV was detected.</p

    TBEV transmission and replication in <i>I</i>. <i>ricinus</i> ticks.

    No full text
    <p>Each adult tick female was injected with 500 pfu of virus (as specified). After 14 days two adult females were co-fed with 15 nymphs for three days and virus titres in females and nymphs were determined by plaque infectivity assay. Left and right panels illustrate biological effects of gene replacements in Vs-based and Hypr-based chimaeras respectively. Mean values are shown with error bars indicating 95% confidence intervals. A) Transmission rate of TBEV between co-feeding ticks is presented as a proportion of nymphs that acquired TBEV infection after co-feeding with infected female ticks. Depending on levels of statistically significant differences (Mann-Whitney test) between chimaeric and control viruses, results are labelled with double (p < 0.01) or single asterisks (p < 0.05). B) Virus titres of TBEV in nymphs and females of <i>I</i>. <i>ricinus</i>. Vs- and Hypr-based chimaeras are identified as green and red bars respectively; the control viruses are shown as empty bars. Highly significant differences (p < 0.05, unpaired two-tailed t-test) between chimaeric and control viruses are labelled with an asterisk.</p

    TBEV replication in mice following transmission from ticks.

    No full text
    <p>Mice infected via tick bites during the NVT experiments were observed for 21 days and cumulative numbers of challenged and moribund mice were analysed. A) Survival dynamics of mice infected with Vs-based (green lines/bars) chimaeras; B) Survival dynamics of mice infected with Hypr-based (red lines/bars) chimaeras. The probabilities of survival were estimated using Kaplan-Meier method; C) Correlation between mouse morbidity and infectious dose of TBEV in adult tick salivary glands following the termination of co-feeding. The data are arranged in descending order of mouse morbidity. The trend lines were drawn using the order 4 polynomial method (R<sup>2</sup> ≥ 0.95). The (r) value in the top right corner of the chart reflects the Pearson’s coefficient of correlation between datasets.</p

    Vs and Hypr chimaeric viruses.

    No full text
    <p>A) The polyproteins, with individual proteins of Hypr virus (grey bars) and Vs virus (white bars) are flanked with 3`UTR (thick and thin lines for Hypr and Vs respectively). B) Schematic representation of the 3`UTRs., Numbers specify nucleotide positions in 3’UTRs following the stop codon. Internal deletions present in the Hypr and Vs genomes are identified by the numbers corresponding to those of the Hypr-long 3’UTR. Intermediate plasmids, constructed to recover Hypr, Vs and chimaeric Hypr/Vs infectious virus, are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0158105#pone.0158105.s001" target="_blank">S1 Fig</a>.</p

    Virion stability.

    No full text
    <p>Identical aliquots of virus suspension were treated as indicated in chart legend (see also <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0158105#sec013" target="_blank">Materials and Methods</a>) with virus titres determined by plaque infectivity assay. Error bars show 95% confidence intervals from the mean across three replicates.</p

    Sequential development of several RT-qPCR tests using LNA nucleotides and dual probe technology to differentiate SARS-CoV-2 from influenza A and B

    No full text
    Sensitive and accurate RT-qPCR tests are the primary diagnostic tools to identify SARS-CoV-2-infected patients. While many SARS-CoV-2 RT-qPCR tests are available, there are significant differences in test sensitivity, workflow (e.g. hands-on-time), gene targets and other functionalities that users must consider. Several publicly available protocols shared by reference labs and public health authorities provide useful tools for SARS-CoV-2 diagnosis, but many have shortcomings related to sensitivity and laborious workflows. Here, we describe a series of SARS-CoV-2 RT-qPCR tests that are originally based on the protocol targeting regions of the RNA-dependent RNA polymerase (RdRp) and envelope (E) coding genes developed by the Charite Berlin. We redesigned the primers/probes, utilized locked nucleic acid nucleotides, incorporated dual probe technology and conducted extensive optimizations of reaction conditions to enhance the sensitivity and specificity of these tests. By incorporating an RNase P internal control and developing multiplexed assays for distinguishing SARS-CoV-2 and influenza A and B, we streamlined the workflow to provide quicker results and reduced consumable costs. Some of these tests use modified enzymes enabling the formulation of a room temperature-stable master mix and lyophilized positive control, thus increasing the functionality of the test and eliminating cold chain shipping and storage. Moreover, a rapid, RNA extraction-free version enables high sensitivity detection of SARS-CoV-2 in about an hour using minimally invasive, self-collected gargle samples. These RT-qPCR assays can easily be implemented in any diagnostic laboratory and can provide a powerful tool to detect SARS-CoV-2 and the most common seasonal influenzas during the vaccination phase of the pandemic
    corecore